Wed, December 8, 2021
Tue, December 7, 2021
Mon, December 6, 2021

Neena Bitritto-Garg Maintained (ACAD) at Hold with Increased Target to $28 on, Dec 7th, 2021

Neena Bitritto-Garg of Citigroup, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $25 to $28 on, Dec 7th, 2021.

Neena has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Neena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Neena


  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021